Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Stealth DNA May Control Aging

November 3, 2010 11:35 am | by Massachusetts Institute of Technology | News | Comments

Research on Amish people reveals a link between a rare genetic pattern and healthy aging.

Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Nov. 3, 2010 /- Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified...

TOPICS:

PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement and video regarding the mid-term election: Watch the Video "Congratulations to all of the candidates who...

TOPICS:
Advertisement

Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., Nov. 3, 2010 /PRNewswire-USNewswire/ -- A global contract research organization will expand its operations in Chester County and create more than 80 new jobs within three years, the Department of Community and Economic Development announced today. PPD Inc. is planning to...

TOPICS:

IRS Awards $244,479 Grant to STB Lifesaving Technologies®

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Nov. 3, 2010 /- STB Lifesaving Technologies ® today announced that it has been awarded a Qualifying Therapeutic Discovery Project (QTDP) grant from the U.S. government in the amount of $244,479.   The Qualifying Therapeutic Discovery Project was included in the...

TOPICS:

Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Nov. 3, 2010 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at IMPACT 2010 held at...

TOPICS:

Champions Biotechnology Awarded $1.46 million in Grants

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Nov. 3, 2010 /- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR ), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today received $1.46 million in grants as part of the Qualifying...

TOPICS:

ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities

November 3, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESTON, Va., Nov. 3, 2010 /PRNewswire-USNewswire/ -- The American College of Radiology (ACR) distributed 1,500 copies of the College's Mammography Case Review ( MCR5 ) educational CD-ROM free of charge to physicians in approximately 600 ACR-accredited mammography facilities throughout New...

TOPICS:
Advertisement

Researchers discover new genetic factors associated with successful aging in the Amish

November 3, 2010 9:35 am | by EurekAlert | News | Comments

(American Society of Human Genetics) A number of the scientific papers presented at the American Society of Human Genetics 2010 Annual Meeting will provide information about important new research findings in statistical genetics and genetic epidemiology. One such research abstract...

TOPICS:

Specific changes in the brain associated with sleep deprivation described in new study

November 3, 2010 8:37 am | by EurekAlert | News | Comments

(Allen Institute for Brain Science) Researchers at the Allen Institute for Brain Science and SRI International have published the most systematic study to date of the effects of sleep deprivation on gene expression in the brain. The findings have implications for improving the...

TOPICS:

Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of 'SOFTISSUE - The Issue of Soft Tissue,' Featuring James J. Chao, M.D., FACS, ...

November 3, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SINGAPORE, Nov. 3, 2010 /- Singapore company Novus Scientific Pte. Ltd today announced the successful hosting of Asia's 1st "SOFTISSUE – The Issue of Soft Tissue" educational series, together with the Singapore Association of Plastic Surgeons (SAPS) on 1st November 2010. This...

TOPICS:

Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results

November 3, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Nov. 3, 2010 /- Cyberonics, Inc. (Nasdaq: CYBX ) today announced that the company will report financial results for the second quarter ended October 29, 2010 of its fiscal year ending April 29, 2011 on Monday, November 22, 2010 at 8:00 AM ET.  The company will conduct a...

TOPICS:

Georgia Tech Hosts Sickle Cell Disease Symposium

November 3, 2010 8:34 am | by Georgia Tech Institute of Technology | News | Comments

Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder.

TOPICS:

Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions

November 3, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Nov. 3, 2010 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today announced a collaboration with Sony DADC Austria AG for the co-development and manufacture of plastic consumables...

TOPICS:

Karyopharm collects $20M in first funding round

November 3, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Stealthy pharmaceutical startup Karyopharm Therapeutics Inc., born out of the ashes of Epix Pharmaceuticals, has raised a $20 million Series A financing round from unnamed backers, officials said.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading